Related Experiment Video

Updated: Sep 27, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.4K

Levosimendan improves postoperative heart function recovery and prognosis in patients with heart disease

Yu Liu1, Linli Liu1, Fang Yan1

  • 1Department of Cardiac Surgery, The Second Hospital of Hebei Medical University Shijiiazhuang 050000, Hebei, China.

American Journal of Translational Research
|April 15, 2022
PubMed

Insights

Levosimendan improves cardiac function and quality of life in post-cardiac surgery patients. This treatment also reduces intensive care unit and hospitalization stays, enhancing overall patient prognosis.

Area of Science:

  • Cardiology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Levosimendan is known to reduce mortality and complications in cardiac surgery patients.
  • This study investigates levosimendan's impact on post-operative recovery in heart disease patients.

Purpose of the Study:

  • To evaluate the effect of levosimendan on cardiac function recovery.
  • To assess the impact of levosimendan on quality of life and prognosis after cardiac surgery.

Main Methods:

  • Retrospective study of 93 cardiac surgery patients (53 levosimendan, 40 control).
  • Compared ICU and hospitalization length, hemodynamic parameters (MAP, CVP, HR), cardiac function indices (LVEDV, LVESV, LVEF, CI), and biomarkers (hs-cTnI, CK-MB, NT-proBNP).
  • Analyzed stroke volume index (SVI), left ventricular stroke work index (LVSWI), and systemic vascular resistance index (SVRI).

Main Results:

  • Shorter ICU and hospital stays in the levosimendan group.
  • Improved cardiac function (higher LVEF, CI, SVI, LVSWI) and reduced cardiac stress markers (lower hs-cTnI, NT-proBNP, SVRI) with levosimendan.
  • Enhanced quality of life and reduced mortality risk observed in patients receiving levosimendan.

Conclusions:

  • Levosimendan significantly improves cardiac function post-surgery.
  • The drug enhances patient quality of life and prognosis after cardiac procedures.
  • Levosimendan warrants clinical promotion for its benefits in cardiac surgery recovery.
Abstract

Keywords:
Levosimendancardiac functioncardiac surgeryprognosis

More Related Videos

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.0K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.1K

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
768
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
45
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
539
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
50
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
451